Evidence map›Paper›PMID 31430259›Full record

ArticleThe Journal of clinical investigation2019

Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling.

Shigeki Nishimori, Maureen J O'Meara, Christian D Castro, Hiroshi Noda, Murat Cetinbas, Janaina da Silva Martins, Ugur Ayturk, Daniel J Brooks, Michael Bruce, Mizuki Nagata and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Control of alveolar bone development, homeostasis, and socket healing by salt-inducible kinases.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Stimulation of fracture mineralization by salt-inducible kinase inhibitors.Frontiers in bioengineering and biotechnology · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Structure-based design of selective, orally available salt-inducible kinase inhibitors that stimulate bone formation in mice.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. PTHrP promotes subchondral bone formation in TMJ-OA.International journal of oral science · 2022
    Article
  19. Article
  20. The osteocyte as a signaling cell.Physiological reviews · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Shigeki NishimoriEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Maureen J O'MearaEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Christian D CastroEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Hiroshi NodaEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Murat CetinbasDepartment of Molecular Biology and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Janaina da Silva MartinsEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Ugur AyturkMusculoskeletal Integrity Program, Hospital for Special Surgery, New York, New York, USA.
Daniel J BrooksEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Michael BruceEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mizuki NagataDepartment of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
Wanida OnoDepartment of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
Christopher J JantonEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mary L BouxseinEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Marc ForetzUniversité de Paris, Institut Cochin, CNRS, INSERM, Paris, France.
Rebecca BerdeauxDepartment of Integrative Biology and Pharmacology, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Ruslan I SadreyevDepartment of Molecular Biology and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Thomas J GardellaEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Harald JüppnerEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Henry M KronenbergEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Marc N WeinEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Harvard University · USBeth Israel Deaconess Medical Center · USMassachusetts General Hospital · USUniversity of Michigan · USCentre National de la Recherche Scientifique · FRHospital for Special Surgery · USThe University of Texas Health Science Center at Houston · US

Funding

Tissue Phenotyping CoreP01DK011794 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JUEPPNER, HARALD W. · 1986 to 2023
$44.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Takara Leah Stanley · 1994 to 2026
$31.6M
The role of salt inducible kinases in parathyroid hormone action in boneR01DK116716 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Marc Nathan Wein · 2018 to 2026
$3.8M
PTH Inverse Agonists as Therapy for Jansens DiseaseR01DK113039 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI THOMAS J GARDELLA, HARALD W. JUEPPNER · 2018 to 2026
$3.5M
Skeletal Phenotyping CoreP30AR066261 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI KRONENBERG, HENRY M. · 2014 to 2018
$3.5M
Regulation of glucose utilization by skeletal muscle SIK1R01DK092590 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BERDEAUX, REBECCA L · 2011 to 2021
$3.3M
The role of SIK1 in myogenic differentiation and skeletal muscle repairR01AR059847 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BERDEAUX, REBECCA L · 2011 to 2015
$1.7M
Dissecting the roles of class IIa HDACs in osteocyte biologyK08AR067285 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI WEIN, MARC NATHAN · 2015 to 2019
$698k
Dental Follicle: A Central Regulator of Tooth Eruption and Root FormationR03DE027421 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ONO, WANIDA · 2018 to 2019
$312k
NIAMS NIH HHS K08 AR067285NIAMS NIH HHS P30 AR066261NIAMS NIH HHS R01 AR059847NIDCR NIH HHS R03 DE027421NIDDK NIH HHS P01 DK011794NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK092590NIDDK NIH HHS R01 DK113039NIDDK NIH HHS R01 DK116716
6 · The paper itself

Abstract

The parathyroid hormone 1 receptor (PTH1R) mediates the biologic actions of parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP). Here, we showed that salt-inducible kinases (SIKs) are key kinases that control the skeletal actions downstream of PTH1R and that this GPCR, when activated, inhibited cellular SIK activity. Sik gene deletion led to phenotypic changes that were remarkably similar to models of increased PTH1R signaling. In growth plate chondrocytes, PTHrP inhibited SIK3, and ablation of this kinase in proliferating chondrocytes rescued perinatal lethality of PTHrP-null mice. Combined deletion of Sik2 and Sik3 in osteoblasts and osteocytes led to a dramatic increase in bone mass that closely resembled the skeletal and molecular phenotypes observed when these bone cells express a constitutively active PTH1R that causes Jansen's metaphyseal chondrodysplasia. Finally, genetic evidence demonstrated that class IIa histone deacetylases were key PTH1R-regulated SIK substrates in both chondrocytes and osteocytes. Taken together, our findings establish that SIK inhibition is central to PTH1R action in bone development and remodeling. Furthermore, this work highlights the key role of cAMP-regulated SIKs downstream of GPCR action.

Indexed as

Bone DevelopmentBone RemodelingAnimalsAnimals, NewbornCell ProliferationChondrocytesExtracellular Matrix ProteinsGene DeletionHypertrophyMaleMiceMice, KnockoutMutationOsteoblastsOsteocytesParathyroid HormoneDmp1 protein, mouseExtracellular Matrix ProteinsParathyroid HormoneProtein Serine-Threonine KinasesProtein-Tyrosine KinasesPTH1R protein, mousePtk6 protein, mouseReceptor, Parathyroid Hormone, Type 1salt-inducible kinase-2, mouseSik1 protein, mouseSIK3 protein, mouseBone BiologyBone developmentBone diseaseEndocrinologyOsteoclast/osteoblast biology

Identifiers

PMID31430259
PMCPMC6877304
OpenAlexW2969433938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.